US · Healthcare

NRX Pharmaceuticals Inc (NRXP)

Biotechnology

NRX Pharmaceuticals Inc (NRXP) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NRXP

P/E ratio

18.00

NRX Pharmaceuticals Inc (NRXP) — FAQ

What is NRXP's P/E ratio?

The price-to-earnings (P/E) ratio for NRX Pharmaceuticals Inc (NRXP) is 18.00 (data as of 2026-03-24).

Does NRX Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for NRX Pharmaceuticals Inc (NRXP). Check the MyAverix Finance app for the latest dividend data.

What sector is NRX Pharmaceuticals Inc in?

NRX Pharmaceuticals Inc (NRXP) is classified in the Healthcare sector (Biotechnology industry).

What exchange is NRXP listed on?

NRXP is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)